ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • Abstract Number: OC 56.3

    Identification and Characterization of F9 Deep Intronic Variations in Haemophilia B Patients

    A. Dericquebourg1,2, M. Fretigny1, C. Negrier1,2, C. Vinciguerra1,2, Y. Jourdy1,2

  • Abstract Number: PB0813

    Identification of a Common PROC Gene Mutation in Children with Moyamoya Disease Using Whole Exome Sequencing

    N. Sirachainan1, P. Pongphitcha1, Y. Okuno2, L. Thampratankul1, C. Khongkhatithum1, P. Komvilaisak3, T. Tim-Aroon1, D. Songdej1, D. Wattanasirichaigoon1.

  • Abstract Number: PB0112

    Identification of a Novel PROC Mutation in a Newborn Causing Severe Protein C Deficiency Successfully Treated with Liver Transplantation

    A. Le Moigne1, D. Habes2, G. Hery3, G. Staiti4, V. Fouquet3, C. Baujard4, J. Miatello4, P. Durand4, M. Alhenc-Gelas5, O. Ackermann2, D. Mitanchez6, G. Leverger1, R. Favier7, V. Proulle8, M. Simonin1

  • Abstract Number: PB0903

    Identification of ADP P2y12 Receptor Defect by Functional Assays Using Algorithmic Approach – A Case Series

    R. Dave1, T. Geevar1, J. Mammen1, R. Vijayan1, A. Samuel1, S. Singh1, S. Nair1

  • Abstract Number: OC 37.2

    Identification of an Alternate Covalent Form of Platelet αIIbβ3 Integrin that Selectively Partitions into Focal Adhesions where it Has Extended Residency Time and Altered Function

    A.E. Pijning1, M.T. Blyth2, M. Coote2, F. Passam3, J. Chiu1, P.J. Hogg1

  • Abstract Number: PB0960

    Identification of Marginal Zone B Cells as Key Players in a Mouse Model of Platelet Alloimmunization

    A. Couvidou1, C. Angenieux1, L. Ruch1, C. Gachet1, B. Maitre1

  • Abstract Number: OC 21.4

    Identification of Novel Variants by Panel-based High-throughput Sequencing Associated with Platelet Function Disorders

    H. Schulze1, G. Manukjan1, A. Borst2, E. Klopocki2, O. Andres3, GPOH/GTH study group of Inherited Platelet Disorders

  • Abstract Number: OC 23.4

    Identification of Patients at High Thrombotic Risk in a Large Prospective Cancer Patient Cohort Undergoing Anticancer Treatment

    C. Verzeroli1, M. Marchetti1, S. Bolognini1, S. Gamba1, C. Giaccherini1, L. Russo1, C.J. Tartari1, D. Spinelli2, P. Malighetti2, A. Santoro3, F. De Braud4, G. Gasparini5, M. Minelli6, C. Tondini7, R. Labianca8, F. Giuliani9, F. Petrelli10, S. Barni10, A. Falanga1, A. D'Alessio11

  • Abstract Number: LPB0088

    Identification of Small Interfering RNAs for Allele-selective Silencing of Murine von Willebrand Factor

    Y.K. Jongejan1, R.J. Dirven1, A. de Jong1, B.J.M. van Vlijmen1, J.C.J. Eikenboom1

  • Abstract Number: PB1103

    Identification of Tumor-expressed MicroRNAs Associated with Venous Thrombosis in Colorectal Cancer

    R.J.S. Anijs1, E.H. Laghmani1, B. Ünlü1, S.M. Kielbasa1, H. Mei1, S.C. Cannegieter1, F.A. Klok1, P.J.K. Kuppen1, H.H. Versteeg1, J.T. Buijs1

  • Abstract Number: PB0555

    Identify Clinical and Laboratory Phenotypes of People with Hemophilia in Southwest Nigeria

    T. Adeyemo1, A. Bolarinwa1, L. Adiat1, A. Olatinwo1, O. Opadeyi1, O. Otokiti1, T. Youttananukorn2, D. Coffin2

  • Abstract Number: PB0152

    Identifying Tools to Track Hypercoagulability in COVID-19 Patients. Exploring Global Haemostasis (ROTEM) and Neutrophil Extracellular Traps (NETs) Immunoassays

    S. Stanford1, C. Rea2, A. Roy3, B. Harris3, A. Ashton3, S. Mangles3, T. Everington3, K. Chandrakumaran3, E. Arbuthnot3, T. Cecil3

  • Abstract Number: PB0120

    Identifying Vulnerable Patients with Direct Oral Anticoagulant (DOAC) Levels Outside the Expected Range

    D. Braeken1, R. Bavalia2, Y. Henskens3, H. ten Cate1,4, J. Veenhuizen2, R. Hengeveld5, B. Hutten6, S. Middeldorp2,7, M. Coppens2, A. Stroobants2

  • Abstract Number: PB0834

    Idiopathic Thrombocytopenic Purpura: Conventional Prednisolone vs High-dose Dexamethasone

    C. Lewis1,2, Z. Ng1,3, C. Grove1,2,3

  • Abstract Number: OC 55.1

    IgG2 as Hallmark of Inhibitor Persistence in a Longitudinal Analysis of PUPs in the First 50 Exposure Days to FVIII

    S. Miri1, C. Valsecchi2, L. Schiavone2, A. El-Beshlawy3, M. Elalfy4, V. Ramanan5, P. Eshghi6, S. Hanagavadi7, R. Varadarajan8, M. Karimi9, F.R. Rosendaal10, P.M. Mannucci2, F. Peyvandi11

  • Abstract Number: OC 36.3

    Immature Platelet Count is Associated with Platelet Functional Responses in Patients Receiving Aspirin

    G. Gulati1, D. Hughes1, L. Goudswaard1, I. Hers1, A. Mumford1, K. Burley1

  • Abstract Number: PB0825

    Immature Platelet Fraction in Systemic Lupus Erythematosus-Related Thrombocytopenia: Potential Predictor of Platelet Response to Treatment?

    T. Nguyen1, D. Truong-Pham1, T. Huynh1, T. Nguyen1, T. Tran1, L. Phan-Nguyen1, G. Nguyen-Tran1, T. Tran1

  • Abstract Number: LPB0011

    Immature Platelets as a Biomarker for Disease Severity and Mortality in COVID-19 Patients

    D. Welder1, H. Jeon-Slaughter1, B. Ashraf1, S.-H. Choi1, W. Chen1, I. Ibrahim1, T. Bat1

  • Abstract Number: PB0455

    Immune Complex Formation of Factor VIII (FVIII) with Inhibitors is Modulated by von Willebrand Factor (vWF)

    O. Oleshko1, U. Curth2, A. Tiede1, S. Werwitzke1

  • Abstract Number: PB0377

    Immune Mediators in Pediatric Patients with Chronic Kidney Disease

    A. Silva1, L. Perucci2, R. Silva1, L. Sousa1, A. Talvani2, A.P. Mota1, L. Dusse1, P. Alpoim1

  • Abstract Number: PB0269

    Immune Thrombocytopenia during Covid-19 Pandemic: An Italian Monocentric Experience

    G. Lapietra1, A. Ferretti1, E. Baldacci1, M.L. De Luca1, S.M. Aprile1, F. Barone1, S. Olivieri1, A. Chistolini1, C. Santoro1

  • Abstract Number: PB0303

    Immune Thrombocytopenia Purpura Associated with Novel Coronavirus Infection

    R.M. Camelo1,2, P.C. Gontijo2,3,4

  • Abstract Number: PO128

    Immune Thrombocytopenia Refractory to Corticoid Therapy Secondary to Covid-19. A Single-centre Experience

    B.L. Diaz Jordan1, V.B. Yepez Espinales1, A. Valverde Templado1

  • Abstract Number: PB1011

    Immune Thrombocytopenic Purpura: A Case Report

    A. Berisha1, S. Sadiku1

  • Abstract Number: PB0872

    Immunofluorescence Staining of Blood Smears for the Diagnostics of Platelet Disorders: A Single-center Experience in a Pediatric Hospital

    N. Podoplelova1,2, E. Popova3,1, P. Zharkov2, D. Fedorova2, A. Greinacher4, M. Panteleev1,2,3

  • Abstract Number: PB0549

    Immunogenicity and Safety of Simoctocog Alfa in Previously Treated Patients Switching to Simoctocog Alfa in the GENA Clinical Trial Programme

    M.J. Manco-Johnson1, R.J. Liesner2, A. Tiede3

  • Abstract Number: OC 32.3

    Immunogenicity in the Concizumab Phase 2 Clinical Trials: Clinical Impact of Anti-drug Antibodies

    L. Hummelshøj Landsy1, G. Castaman2, K. Cepo3, P. Lenting4, J. Oldenburg5

  • Abstract Number: PB0138

    Immunothrombosis Biomarkers for Distinguishing COVID-19 Patients from Non-COVID Septic Pneumonia Patients and for Predicting ICU Mortality

    E. Cani1, D. Dwivedi1, K.L. Liaw2, D. Fraser3, C. Yeh4, C. Martin3, M. Slessarev3, S. Cerroni1, A. Fox-Robichaud1, J. Weitz1, P. Kim1, P. Liaw1, DYNAMICS and COVID-BEACONS Investigators

  • Abstract Number: PB1108

    Impact of a Smartphrase Venous Thromboembolism Risk Assessment Tool on Prophylaxis Prescribing Rates in a Gynecologic Oncology Clinic

    M. Duco1, J. MacDonald1, B. Orr1, E. Weeda1, N. Bohm1

  • Abstract Number: PB1049

    Impact of ABO Incompatibility on the Outcome of Hematopoeitic Stem Cell Transplantation

    M. Borhany1, U. Zaidi1, M. Abid1, S. Zafar1, T. Shamsi1

  • Abstract Number: PB0454

    Impact of Adherence to Prophylactic Treatment on Real-world Outcomes in Adults with Severe Haemophilia: A CHESS II Analysis in Europe

    T. Burke1,2, S. Asghar1, J. O'Hara1,2, D. Yee3, S. Kar3

  • Abstract Number: LPB0061

    Impact of Characteristic Inhibition Kinetics of Different FVIII Inhibitors on the Inhibitor Titer Quantification in the Modified Nijmegen-Bethesda Assay

    C. Ketteler1, I. Hoffmann1, S. Davidson2, A. Tiede3, N. Richter1

  • Abstract Number: PB0252

    IMPACT of COVID-19  Associated Coagulopathy in Disease Severity

    F. Santos1, R. Marinho1, M. Carneiro1, R. Matos1, N. Pinho1, L. Moreira1, N. Seidi1, M. Coutinho1, S. Morais1, E. Cruz1

  • Abstract Number: PB0137

    Impact of COVID-19 on Platelet Activity and the Platelet Releasate

    S. Comer1,2, S. Cullivan1,3, P. Szklanna1,2, L. Weiss1,2, S. Cullen4, S. Kelliher5, A. Smolenski6, C. Murphy1,7, H. Altaie8, J. Curran9, K. O'Reilly3,6, A. Cotter6,10,11, B. Marsh6,12, S. Gaine3,6, P. Mallon6,13, B. McCullagh3,6, N. Moran4, F. Ní Áinle1,5,6,14, B. Kevane1,5,6, P. Maguire1,2,15

  • Abstract Number: PB0576

    Impact of COVID-19 Pandemic on the Joint Bleeding Pattern and Prophylactic Management of Hemophilia Patients: A Single Centre Study in a Tertiary Care Centre of Eastern India

    A. Chatterjee1, A.K. De1, M. Bera1, S. Roy1, A. Chowdhury1

  • Abstract Number: PB0205

    Impact of COVID-19 Pandemic on the Quality and Performance of Haemostasis Laboratories

    R.A. Arisz1, P. Meijer2, N.CV Péquériaux3, S.J van de Leur4, M.V Lukens5, M.PM de Maat1, M.J Hollestelle2

  • Abstract Number: PB0130

    Impact of DNA on the Fibrin Clot Structure in Peritoneal Carcinomatosis Patients

    S. Mirshahi1,2, I. Aldybiat2, G. Contant1, M. Pocard2, J. Soria2, M. Mirshahi2

  • Abstract Number: LPB0001

    Impact of Heparin Induced Thrombocytopenia on the Outcomes of Hospitalizations for Acute Myocardial Infarction: Analysis of National Inpatient Sample

    M.U. Almani1, M.J. Tariq1, M. Usman1, M. Qudrat Ullah2, M. Yousuf3, N. Fatima4, E. Edigin1, A. Vij1, J. Gomez Valencia1

  • Abstract Number: PB0713

    Impact of Inherited Bleeding Disorders on Pregnancy and Postpartum Hemorrhage

    N. Fernández Mosteirín1, J.M. Calvo Villas1

  • Abstract Number: PB0901

    Impact of Iron Deficiency Anemia on Bleeding Management in Pediatric Patients with Bernard-Soulier Syndrome and Glanzmann Thrombasthenia: A Single-institution Analysis

    A. Lee1, G. Batsuli1,2

  • Abstract Number: PB0561

    Impact of Prophylactic Treatment on Employment and Disability in Persons with Hemophilia

    P.A. Holme1, C. Qvigstad1, R.C. Tait2

  • Abstract Number: PB0589

    Impact of Switching to Recombinant Factor IX Fc Fusion Protein Prophylaxis: A Qualitative Study

    M. O'Donovan1,2, P. Byrne1, B. O'Mahony3,4, K. Ryan1, N.M. O'Connell1,2, D. Hevey5

  • Abstract Number: PB1021

    Impact of the Common GPVI Polymorphism Is Limited to Intracellular Calcium Response upon Activation

    M. Stepanyan1,2, A. Martyanov1,3, A. Boldova1, A. Filkova1,3, A.K. Garzon Dasgupta1,2, E. Beresneva1, A. Balatsky4, E. Ponomarenko3, A. Ignatova1,3, M. Panteleev1,2,3, A. Sveshnikova1,2,3

  • Abstract Number: PB0217

    Impact of the COVID-19 Pandemic and a National Lockdown on Hospitalizations for Venous Thromboembolism and Pulmonary Embolism in France

    A. Gabet1, C. Grave1, P. Tuppin2, J. Emmerich3, V. Olié1

  • Abstract Number: PB1156

    Impact of Thrombophilia Testing in Splanchnic Vein Thrombosis Management

    R. Rouached1,2, H. Baccouche1,2, A. Laabidi3,2, H. Kechir4,2, J. Boubaker3,2, N. Laamari4,2, N. Ben Romdhane1,2

  • Abstract Number: PB1302

    Impact of Tissue Factor Pathway Inhibitor Gene Polymorphisms (33T/C and 264V/M) on Plasma TFPI Levels and their Influence on Risk of Recurrent Pregnancy Loss in India

    K. Kishor1, A. Sharma1, S. Maharana2, R. Ranjan1, R. Kumar1, S. Tyagi1, R. Saxena3, M. Mahapatra1

  • Abstract Number: LPB0119

    Impact of Vancomycin-induced Shift of the Gut Microbiome in Gram Negative Direction on Plasma Factor VIII:C Levels: Results from a Randomized, Controlled Trial

    G. Grimnes1,2, S. Bhoelan1,3, K. Hindberg1, M. Davids4, M. Nieuwdorp4,5,6, T.E. Mollnes1,7,8, A. Michelsen9,10, T. Ueland1,9,10, S. Braekkan1,2, J.-B. Hansen1,2, V. Tichelaar1,3,11

  • Abstract Number: OC 10.2

    Impairment of Platelet Purinergic Signaling in Sickle Cell Disease

    T. Brzoska1, E.V. Menchikova1, T.W. Kaminski1, R. Vats1, E. Tutuncuoglu1, S.P. Tofovic1, E.K. Jackson1, M.T. Gladwin1, P. Sundd1

  • Abstract Number: PB1217

    Implementation of a Multidisciplinary Surveillance Team to Improve Inferior Vena Cava Filter Retrieval and Outcomes

    S. Chao1, H. Bortz2, H. Stevens3,4,5, J. McFadyen3,4,5, H. Tran3,4

  • Abstract Number: PB0696

    Implementation of a National Reference Service for Activity Testing, Typing, and Genotyping of Hereditary Factor XIII Deficiency (Project BR-13)

    R. Camelo1, J. Moreira2, L.I. Pires Filho3, V. Franco4, C.B. Ferreira5, L.C.C.M. de Souza6, M.D. Tenório7, S. Figueiredo7, S. Lopes8

  • Abstract Number: OC 07.1

    Implementation of Tele-guidance for Patient Self-imaging of Arthropathic Joints Using Mobile Ultrasound Devices –– Results from a Pilot Study

    P. Aguero1, A. Flores1, A. von Drygalski1,2

  • Abstract Number: PB1009

    Importance of Consideration to Differetial Diagnosis of ITP

    N. Mirbehbahani1

  • Abstract Number: PB0883

    Importance of Platelet’s Sialic Acid Residues on Haemostasis and Immune System of Patients with Immune Thrombocytopenia

    N.V. Butta Coll1, M.T. Álvarez Román1, E. Monzón Manzano1, M. Martín Salces1, M.I. Rivas Pollmar1, E. García Arias-Salgado1, P. Acuña1, S. García Barcenilla1, E. González Zorrilla1, T. Cebanu1, V. Jiménez Yuste1

  • Abstract Number: PO133

    IMPROVE Score and Coagulopathy Screening in Coronavirus Disease 2019 Patients

    C. Syukur1, H. Haroen1, L.W.A. Rotty1, P.F.C. Lasut1, C. Hendrata1, C.T.H. Kawengian1

  • Abstract Number: OC 06.1

    Improved Overall Survival with Warfarin Compared with Direct Oral Anticoagulants in Cancer-associated Venous Thromboembolism: A SEER-medicare Analysis

    T. Chiasakul1,2, A.M Khan1, R. Redd3, R. Patell1, E.P McCarthy1,4, D. Neuberg3, J.I Zwicker1

  • Abstract Number: LPB0041

    Improved Patient-reported Treatment Satisfaction with Rivaroxaban as Compared to Low Molecular Weight Heparins for Cancer Patients with Acute Venous Thromboembolism – Results from the CONKO-011 Trial

    H. Riess1, M. Sinn2, A. Lohneis3, M. Hellmann4, J. Striefler1, T. Südhoff5, U. Pelzer1, M. Stahl6, A. Schlenska-Lange7, A. Krziwanie8, R. Trappe9, S. Rutzner10, J. Heinz11, K.-D. Wernecke12

  • Abstract Number: PO108

    Improving of the of Biomechanical Parameters in an Experimental Animal Abdominal Aorta Model of Thick- cap Fibroatheromatic Plaque Using Ultrasound-guided High-dose Atorvastatin-loaded PESDA Microbubbles and Low Level Focused Shock Waves

    H. Mehrad1,2, H. Ahmadi Noubari3,2

  • Abstract Number: OC 65.3

    Improving Outcomes with Integrated Care of Patients with Atrial Fibrillation and Multimorbidity Using Mobile Health Technology: A Report from the mAFA II Trial

    Y. Guo1, G.YH Lip2

  • Abstract Number: NUR 01.3

    Improving Post-Thrombotic Syndrome (PTS) Care in Children: A Child’s Voice

    J. Vincelli1, L.R. Brandao1, N. Amiri1, R. De1, S. Williams1, L. Avila1

  • Abstract Number: PB0793

    In Children Receiving Long-term Anticoagulation Decreased Bone Mineral Density is Associated with Pubertal Development

    K. Thom1, C. Male1, F. Haufler1, A. Raimann1

  • Abstract Number: PB0566

    In vitro Analysis of Coagulation Function in Emicizumab-treated Hemophilia A Patients with Inhibitors under Immune Tolerance Induction Treatment

    Y. Nakajima1, H. Tonegawa1, M. Noguchi-Sasaki2, K. Nogami1

  • Abstract Number: PB0362

    In vitro Neutralization of Unfractionated Heparin for the Measurement of Thrombin Generation with the STG-drugScreen Reagent on ST Genesia

    S. Fontaine1, M. Bourdin1, M.-A. Bildan1, O. Kerleau1, M. Lambert1, F. Depasse2, O. Mathieu1

  • Abstract Number: PB1082

    Inappropriate Direct Oral Anticoagulant Dosing in a Spanish Cohort with Atrial Fibrillation

    B. Navarro Almenzar1, J.J. Cerezo Manchado2, F. García Candel3

  • Abstract Number: PB0763

    Incidence and Correlation of Thrombocytopenia to Blood Stream Infections; Does this Correlation Really Matter?

    N. Anwar1, N. Fatima1, H.-u.- Mujtaba1, T. Shamsi1

  • Abstract Number: PB1100

    Incidence and Impact of Venous Thromboembolism and Major Bleeding in Patients with Glioblastoma

    F.H.J. Kaptein1, M.A.M. Stals1, E. Klaase1, M.Y. Kapteijn1, R. van Eijk2, S.C. Cannegieter1,3, S.G. van Duinen2, M.J.B. Taphoorn4,5, L. Dirven4,5, H.H. Versteeg1, J.T. Buijs1, M.V. Huisman1, J.A.F. Koekkoek4,5, F.A. Klok1

  • Abstract Number: OC 64.4

    Incidence and Predictors of Post-thrombotic Syndrome: Results from GARFIELD-VTE

    P. Prandoni1, A.E. Farjat2, S. Haas3, A.G. Turpie4, H. Bounameaux5, S. Schellong6, S.Z. Goldhaber7, G. Kayani2, M. Carrier8, B. Jacobson9, W. Ageno10, J.I. Weitz11, S. Goto12, P. Angchaisuksiri13, L.G. Mantovani14,15, A.K. Kakkar2,16

  • Abstract Number: PB1207

    Incidence and Treatment Pattern of Venous Thromboembolism from 2014 to 2018: The 3rd Korean Nationwide Study

    H.-G. Hwang1, J.H. Lee2, S.-A Kim2, Y.-K. Kim3, H.-Y. Yhim4, J. Hong5, S.-M. Bang2.

  • Abstract Number: PB0438

    Incidence Comparison and The Antiplatelet Effect on Bleeding Risk Between Chronic Kidney Disease Undergoing Haemodialysis and Peritoneal Dialysis: A Meta-analysis of Cohort Studies

    B.P. Putra1, F.N. Putra2

  • Abstract Number: PB0267

    Incidence of Disseminated Intravascular Coagulation (DIC) in Critical Patients with Covid-19

    C.F. Hernandez Mata1, N. Fernández Mosteirín1, I. Sancho Val1, M.d.M. Herrero Gutierrez1, A. Esteban Molina1, M. Peiro Chamarro1, A. Gómez Martínez1, S. Martín-Consuegra Rámos1, M. Moreno Carbonell1, M. Civeira Marín1, E. González Gómez1, C. Rodríguez Lefler1, A. López Peña1, M.S. Ordas Miguelez1, P.E. Lopez Gomez1, J.M. Calvo Villas1

  • Abstract Number: PB0860

    Incidence of Heparin Induced Thrombocytopenia 2009-2017: Analysis of the National Inpatient Sample Database

    Y. Hayashi-Tanner1, M. Gaddam1, S. Frankki1, A. Borgert1, L. Rosenstein1

  • Abstract Number: PB0861

    Incidence of Heparin-induced Thrombocytopenia in Patients Treated with Mechanical Circulatory Support: Results from a Prospective Study

    A. Gaupp1, O. Hidiatov1, S. Nowak-Harnau2, A. Straub3,4, H. Häberle3, P. Rosenberger3, T. Bakchoul1,2, K. Althaus1,2

  • Abstract Number: PB0302

    Incidence of Spontaneous Iliopsoas Hematoma in COVID-19 Patients

    G. Sottilotta1, C. Mangano2, R. Basile2, C. Falcone3, F. Luise4, D. Megalizzi1, G.M. Nicolò5, V. Oriana1, A. Piromalli4

  • Abstract Number: PB1231

    Incidence of Thrombohaemorrhagic Complications in the Periprocedural of Oral Anticoagulant Treatment with Vitamin K Antagonists

    M. Argüello Marina1, I. Gutiérrez Jomarrón1, L. Castilla García1, E. Flores Ballester1, I. Sánchez Prieto1, S. Valenciano Martínez1, J.M. Aspa Cilleruelo1, C. Martínez Vázquez1, G. López de Hontanar Torres1, P.A. Rodríguez Barquero1, M. López Rubio1, J. García Suárez1

  • Abstract Number: PB1166

    Incidence of Thrombosis in Patients with MTHFR C677T Homozygosity and Hyperhomocysteinemia

    G.M. Nicolò1, G. Sottilotta2, F. Luise3, V. Oriana2, A. Piromalli3

  • Abstract Number: PB1206

    Incidence of Venous Thromboembolic Disease during Primary Hyperparathyroidism: A 20-year Single Center Study

    M. Orlova1, Y.J. Zin1, M.L. Posadas Martínez1, M.F. Grande Ratti1, D.H. Giunta1, M. Burgos1, F.J. Vázquez1

  • Abstract Number: PB0505

    Incorporating Patient Reported Outcomes into Clinical Practice: A 360-degree Clinical Evaluation for Better Care and Treatment of People with Hemophilia through myWBDR and myPROBE

    T. Youttananukorn1, D. Coffin1, S. Diop2, C. Hermans3, B. Konkle4, C. Lambert5, D. Noone6, J. O'Hara7, G. Pierce1, M.W Skinner8,9, A. Iorio10

  • Abstract Number: PB0916

    Increased Cleavage of VWF by ADAMTS13 Might Reduce High-molecular-weight VWF Multimers, Leading to Acquired von Willebrand Syndrome in Patients with Essential Thrombocythemia

    M. Kubo1,2, H. Kashiwagi3, H. Yagi4, Y. Seki5, A. Hasegawa2, H. Tanaka2, I. Amano2, Y. Tomiyama6, M. Matsumoto1

  • Abstract Number: OC 17.2

    Increased Levels of Coagulation Factor V in Atherosclerotic Plaques – An Immune Regulated Response?

    B. Stavik1, M. Seierstad Andresen1, S. Holm1, M. Skjelland1,2, M. Tinholt1, P.M. Sandset2,2, N. Iversen1, B. Halvorsen1,2

  • Abstract Number: OC 33.3

    Increased Plasma Concentration of Pentraxin 3 and Fibroblast Growth Factor 2 in Preeclampsia

    F. Santiago de Oliveira1, L. de Oliveira Perucci2, L. Maria Sant'Ana Dusse1, P. Nessralla Alpoim1, A. Abalen Martins Dias1

  • Abstract Number: PB0496

    Increased Prevalence of Age-related Comorbidities and Health Service Utilization among Adult Men with Hemophilia in Alberta, Canada

    A.U. Alam1, C. Wu1, H. Sun1

  • Abstract Number: PB0705

    Increased Risk for Re-bleeding after Hemostatic Challenges in Patients with a Mild to Moderate Bleeding Tendency

    D. Mehic1, G. Neubauer1, A. Kaider2, C. Ay1, I. Pabinger1, J. Gebhart1

  • Abstract Number: PB0146

    Increased Thrombin Generation in COVID-19 is Mediated by Platelet-dependent and -Independent Mechanisms

    A.S. Eustes1, J. Swamy1, S. Kudchadkar1, M. Jensen1, K.M. Wilson1, U. Perepu1, F. Miller2, S.R. Lentz1, S. Dayal1

  • Abstract Number: PB0198

    Increased von Willebrand Factor (VWF) and Factor VIII (FVIII) Levels in Severe Acute Respiratory Syndrome Sars-Cov2-positive Pneumonia Compared with Severe Acute Respiratory Syndrome Sars-Cov2-negative: A Case-control Study

    M. Sacco1, R. De Cristofaro2,1, G. Liuzzo3, S. Lancellotti2, D. Pedicino3, F. Andreotti3

  • Abstract Number: PB0242

    Indices of the Hemostasis System in Patients with COVID-19 Depending on the Outcome

    E. Klychnikova1, S. Petrikov1, K. Popugaev1, E. Tazina1, S. Badygov1

  • Abstract Number: OC 57.2

    Individual Benefits and Harms of Extended Anticoagulation in Patients with Venous Thromboembolism: The VTE-PREDICT Model

    M.A. de Winter1, J.A.N. Dorresteijn2, M. Carrier3, A.T. Cohen4, J.-B. Hansen5, H.A.H. Kaasjager1, S. Middeldorp6, G.E. Raskob7, H.T. Sørensen8, F.L.J. Visseren2, P.S. Wells3, H.R. Büller9, M. Nijkeuter1

  • Abstract Number: PB0046

    Induced Forms of α2-Macroglobulin Neutralize Heparin and Direct Oral AntiCoagulant Effects

    G. Jourdi1,2,3,4, J. Abdoul1, V. Siguret1,5, X. Decleves6,2, E. Frezza7, C. Pailleret1,8, I. Gouin-Thibault9,10, S. Gandrille1,11, N. Neveux2, C.-M. Samama1,2, S. Pasquali7, P. Gaussem1,11

  • Abstract Number: PB0648

    Infectious Complications in Hemophilia Patients

    H. Khachatryan1,2,3, G. Tamamyan1,2, I. Melnichenko1,2, L. Sahakyan1, L. Petrosyan1, S. Danelyan1, S. Hovhannisyan1,2, A. Movsisyan1,2, L. Hambardzumyan1,2, N. Sargsyan4,2,3

  • Abstract Number: PB0460

    Influence of Activated Factor XI on Simultaneous Thrombin Generation and Fibrin Clot Lysis in Factor Deficiencies

    I. Tarandovskiy1, W.C. Chang1, M. Ovanesov1

  • Abstract Number: PB0243

    Influence of C-reactive Protein on Thrombin Generation Assay

    M. Didembourg1, J. Douxfils1,2, F. Mullier3, M. Hardy4, J. Favresse1,5, L. Morimont1,2

  • Abstract Number: PB0061

    Influence of Low-generation Polyamidoamine (PAMAM) Dendrimers on Structure and Function of Fibrinogen, Generation, Amidolytic and Coagulating Activity of Thrombin in vitro

    L. Mukhametova1,2, R. Aisina1, E. Ivanova1

  • Abstract Number: PB0069

    Influence of Para-sulfonato-calixarenes on Components of Coagulation System

    E. Ivanova1, R. Aisina1, K. Gershkovich2

  • Abstract Number: PB0621

    Influence of Pregnancy on the Pharmacokinetic Profile of a Severe Hemophilia A Female

    L. Costa1, A. Ferreira1, M. Coutinho1, M. Pereira1, E. Cruz1, S. Morais1

  • Abstract Number: PB0062

    Influence of Tissue-factor Pathway Inhibitor on Thrombin Generation Assay

    M. Didembourg1, J. Douxfils1,2, A. Carlo3, L. Morimont1,2

  • Abstract Number: PB0802

    Inherited Antithrombin Deficiency in Childhood: A Multicenter National Study

    A. Unuvar1, N. Sarper2, U. Demirsoy2, I. Eker3, N. Eroglu3, Z. Kaya4, D. Aslan4, N.O. Karadas5, K. Kavakli5, N. Ozbek6, N. Yarali6, A. Canbolat7, T. Celkan8, M. Evim9, S. Karaman1, H. Oren10

  • Abstract Number: PB0719

    Inherited Factor XIII Deficiency: A Mild and a Severe Case Reports

    A.C. Gusmão1, N.N.S. Magalhães1, R.D.M. Almeida1, A.C.A. Santos2, T.S. Espósito2, L.O.W. Rodrigues3, O.F. Santos4, J.A.S. Lopes4, D.O.W. Rodrigues5,2

  • Abstract Number: OC 43.3

    Inhibition of ADAMTS13 Rescues Acquired von Willebrand Syndrome in a Preclinical Left Ventricular Assist Device Animal Model

    S.J Deconinck1, C. Nix2, S. Barth2, E. Bennek-Schöpping2, A.-S. Schelpe1, E. Roose1, I. Pareyn1, A. Vandenbulcke1, J. Muia3, C. Vandenbriele4, B. Meyns5, C. Tersteeg1, S.F De Meyer1, S. Jacobs5, K. Vanhoorelbeke1

  • Abstract Number: PB0995

    Inhibition of ADP and Thromboxane A2 Production Results in Decreased Global Platelet Contraction, but Thromboxane A2 Inhibition Plays a Greater Role in Limiting Local Platelet Contraction

    K. Trigani1, S. Diamond1

  • Abstract Number: OC 28.1

    Inhibition of Neutrophil Extracellular Traps Reveals their Differential Role in the Pathogenesis of Abdominal Aortic Aneurysms in Distinct Mouse Models

    N. Ibrahim1, S. Bleichert1, J. Klopf1, V. Knöbl1, A. Brandau1, A. Busch2,3, M. Bailey4,5, W. Eilenberg1, C. Neumayer1, C. Brostjan1

  • Abstract Number: LPB0131

    Inhibition of Surface-induced Platelet Activation on Hydrogel Films

    G. Apte1, A. Lindenbauer1, J. Schemberg1, H. Rothe1, T.-H. Nguyen1

  • Abstract Number: OC 73.1

    Inhibition of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) to Accelerate Clot Lysis in Patients with Acute Pulmonary Embolism: A Phase 2 Randomized Study

    T. Vanassche1, R.P Rosovsky2, F. Moustafa3,4, H.R Büller5, A. Segers6, I. Patel7, M. Shi8, N. Miyoshi9, V. Mani10, Z. Fayad10, J. Schmidt3,4, M.A Grosso7, V.F Tapson11, P. Verhamme1, M.V Huisman12, DS1040 Study Group

  • Abstract Number: PB0500

    Inhibitor Development upon Switch from Plasma-derived to Recombinant FVIII in PUPs with Severe Haemophilia A: Preliminary Analysis from the PUP-SWITCH Study

    S. Miri1, R.K. Kavakli2, S. Halimeh3, G. Nicolò4, D. Gürlek Gökçebay5, N.Y. Özbek5, T. Celkan6, M. Karimi7, A. Shahsavani7, B.T. Gunes8, B. Atabay8, Z. Kaya9, Y. Ay10, Y. Oymak11, S. Akbayram12, B. Yılmaz13, E. Kazanci14, P.M. Mannucci4, F.R. Rosendaal15, F. Peyvandi16, PUP-SWITCH Study Group

  • Abstract Number: PB0647

    Inhibitors in Non Severe Haemophilia A (NS-HA): A Case Report

    M. R. Lopez1, E. Lopez Ansoar1, O. Dominguez Muñiz1, A. Nieto Vazquez1, C. Albo Lopez1

  • Abstract Number: OC 28.2

    Innocuous Levels of Pulmonary Thrombosis Protect against Inflammatory Lung Injury via Endothelial Alox15 and HIF1α

    C. Evans1, X. Zhang1, N. Machireddy1, Y.-Y. Zhao1

  • Abstract Number: PB1170

    Inpatient Thrombophilia Testing – Adding Unnecessary Cost to the Clot?

    S. Bandikatla1, A. Dadlani1, A. Pinter1, S. Maharaj2, A. Rojan2

  • Abstract Number: PB1024

    Integrin αIIbβ3 Regulates Platelet Procoagulant Activity in the Lung

    T. Brzoska1, T.W. Kaminski1, R. Vats1, E. Tutuncuoglu1, M.T. Gladwin1, P. Sundd1

  • Abstract Number: OC 19.4

    Interaction between the Von Willebrand Factor and ADAMTS13 on VTE Risk in Women. Results from the Retrove Project

    D. Llobet1, C. Vallvé1, S. Mojal1, M. Carrasco1, N. Vilalta1, J. Mateo1, M. Corrochano1, J.A. Millón1, J.C. Souto1

  • Abstract Number: PB1006

    Interaction of Blood Platelets with Engineered Fibrinogen Scaffolds of Different Topographies

    M. Kenny1, S. Stamboroski2,3, R. Taher1, D. Brüggemann2, I. Schoen1

  • Abstract Number: PB0122

    Interaction of Phenyramidol HCl and Warfarin: A Case Series Report

    B. Murat1, E. Kivanc1, R. Dizman1, S. Murat2

  • Abstract Number: PB0103

    Interaction of the Factor IXa with the Subpopulations of Activated Platelets

    P.A. Soloveva1,2, N.A. Podoplelova1,3, F.I. Ataullakhanov1,2,3,4, M.A. Panteleev1,2,3,4

  • Abstract Number: PB1297

    Interactions of Anemia with Race and Peripartum Transfusion in Three Large US Registries

    E. Davis1, R. Amdur2, H. Ahmadzia3

  • Abstract Number: PB0506

    Interim Analysis of the PREVENT Study: Real World Prospective Data from Children and Adolescents with Haemophilia A or B Treated with Recombinant Factor VIII Fc (rFVIIIFc) or Recombinant Factor IX Fc (rFIXFc)

    C. Heller1, C. Bidlingmaier2, C. Escuriola3, N. Hagedorn4, J. Oldenburg5, J. van den Boom6, H. Malmström7, E. Santagostino8, A. Tiede9

  • Abstract Number: OC 28.3

    Interleukin-4 Signaling Enhances Survival of Circulating Monocytes in vivo

    P. Haider1, J. Kral-Pointner1,2, M. Salzmann1, S. Bleichert1, W. Schrottmaier1, C. Kaun1, M. Brekalo1, C. Hengstenberg1, M. Fischer1,3, W. Speidl1, K. Huber4,5, S. Knapp1,6, F. Brombacher7, C. Brostjan1, J. Wojta1,2, P. Hohensinner1,2

  • Abstract Number: PO111

    Intermediate Stage Atherosclerosis Regression Using Lipid-based Encapsulated Methotrexate Nanoparticles-mediated B-mode Ultrasound-guided Pulsed Low Level Focused Ultrasound Sonoporation Therapy

    H. Mehrad1,2, M. Kasiri2

  • Abstract Number: PB0948

    Intermittent Prophylaxis for Heavy Menstrual Bleeding in Von Willebrand Disease

    P. Laguna1, A. Laguna2, M. Matysiak1

  • Abstract Number: PB1267

    International Multicentric Study: Laboratory in Patients Treated with Apixaban or Rivaroxaban in Latin America (Larila): Final Results

    E. Cortina1,2, D. Garcia3,2, G. Conte4,2, M.C. Guillermo5,2, M. Cúneo4,2, P. Turcatti5,2, R. Izaguirre1,2

  • Abstract Number: PB1229

    International Survey of Secondary Thromboprophylaxis Practice Patterns in Pediatrics

    H.P. Wilson1, R. Capio1, I. Aban1, N. Goldenberg2

  • Abstract Number: PB0581

    Intracranial Haemorrhage (ICH) in Egyptian Children with Haemophilia A and B: A 15 Year Retrospective Single Center Study

    M. Abdelwahab1

  • Abstract Number: PB0610

    Intracranial Hemorrhage in Hemophiliac Patients at Chiang Mai University Hospital: A 10-year Retrospective Study

    J. Khamyuang1, P. Charoenkwan1, L. Satitsamitpong1, S. Sittipreechacharn1, C. Chai-Adisaksopha1, R. Natesirinilkul1

  • Abstract Number: LPB0078

    Intracranial Involvement and Neurologic Manifestations in Lemierre Syndrome: Analysis of 712 Patients

    L. Valerio1, T. Nicoletti2, G. Corsi3, S. Granziera4, M. Jankowski1, A. Pecci5, C. Sacco6, F. Zane7, S.V. Konstantinides1, S. Barco8

  • Abstract Number: LPB0030

    Investigating Impact of von Willebrand Factor Deficiencies on the Biogenesis of Weibel-Palade Bodies and Endothelial Cells Signaling Pathways

    H. Yadegari1,2, M.A. Jamil2, N. Marquardt2, O. El-Maarri2, J. Oldenburg2

  • Abstract Number: PB0920

    Investigating Pathomolecular Mechanisms von Willebrand Disease Variants Located in a Domains of the von Willebrand Factor

    H. Yadegari1, A. Biswas1, S. Sadangi1, J. Oldenburg1

  • Abstract Number: OC 66.1

    Investigating the Resistance of ADAMTS13 towards Protease Inhibitors

    K. Singh1,2, S. Sohrabipour1,2, H. Madarati1,2, T. Sparring1,2, C. Kretz1,2

  • Abstract Number: PB1034

    Investigation of Core and Shell Platelet Mechanics through P2Y12 Antagonism

    M. DeCortin1, S. Diamond1

  • Abstract Number: OC 75.2

    Investigation of Early Outcomes Following Adeno-associated Viral Gene Therapy in a Canine Hemophilia Model

    P. Batty1, B. Yates2, D. Hurlbut1, S. Siso-Llonch2, A. Menard3, H. Akeefe2, T. Christianson2, P. Colosi2, L. Harpell1, S. Liu2, A. Mo1, A. Pender1, G. Veres2, C. Vitelli2, A. Winterborn4, S. Bunting2, S. Fong2, D. Lillicrap1

  • Abstract Number: PO169

    Investigation of Hereditary Thrombophilia in Women with Recurrent Fetal Loss in LUMHS Hyderabad

    K. Ilyas1, I. Ujjan1, B. Bhatti1, A. Naz1, S. Abbasi1

  • Abstract Number: OC 20.2

    Investigation of Preterm Intraventricular Hemorrhage Induced Inflammatory Response and microRNA Levels by Heme and Hypoxia in Human Choroid Plexus Epithelial Cells

    Z. Fejes1, M. Pócsi1, A. Balla1, E. Balogh2, A. Tóth2, V. Jeney2, Á. Rusznyák3, F. Fenyvesi3, A. Nagy4, J. Kappelmayer1, B. Nagy Jr.1

  • Abstract Number: PB0010

    Investigation of Red Blood Cells Influence on Atherosclerotic Plaque by Scanning Flow Cytometry

    E. Yastrebova1,2, A. Karpenko2

  • Abstract Number: PB0899

    Investigation of the Epidemiology of Inherited Platelet Disorders in Patients Attending the Royal Hospital, Muscat, Oman

    R. Al Ghaithi1, S. Al Hashami1, N. Al Amri1, S. Al Shiyadi1, R. Al Lawati1, R. Al Busaidi1, H. Ambusaidi1, S. Al Lamki2, M. Al Yahyai1, M. Al Riyami1, M. Al Musalhi1, I. Al Salmi3

  • Abstract Number: PB0867

    Investigations of the Impact of Sialidase-mediated Changes on Bleeding Using a Humanized in vivo Mouse Model

    L. Pelzl1, A. Singh1, J. Zlamal1, I. Marini1, K. Althaus1,2, T. Bakchoul1,2

  • Abstract Number: PB0991

    Iron Repletion Decreases Platelet Count in Iron Deficient Premenopausal Women

    B. Elstrott1, H.H.S. Lakshmanan2, J. Aslan2, J.J. Shatzel3,2

  • Abstract Number: PB1139

    Is Hematopoietic Clonality of Indetermined Potential a Risk Factor for Pulmonary Embolism?

    S. Soudet1, G. Jedraszak1, O. Evrard1, L. Garcon1, J.P. Marolleau1, M.A. Sevestre1.

  • Abstract Number: PB0015

    Is Microvessel Perfusion Associated with Platelets in Acute Cerebrovascular Disorders?

    P.P. Wadowski1, C. Schörgenhofer2, T. Rieder2, S. Ertl1, J. Pultar1, W. Serles3, T. Sycha3, F. Mayer3, R. Koppensteiner1, T. Gremmel1, B. Jilma2

  • Abstract Number: PB0273

    Is Procalcitonin Involved on the Severity of COVID-19?

    A. Zakeri1, S. Matin1, E. Rezaei Ghalechi2

  • Abstract Number: LPB0143

    Is standard dose thromboprophylaxis (TP) as recommended by the Royal College of Obstetricians and Gynaecologists (RCOG) adequate in pregnancy for women with prior venous thrombo-embolism (VTE)?

    E. Treharne1, A. Alexander2, E. Jackson2, B. Myers3

  • Abstract Number: PB0474

    Is Standardisation the Key? FVIII Inhibitor Results: A UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) Exercise

    A. Lowe1, S. Kitchen1, I. Jennings1, I. Walker1

  • Abstract Number: PO113

    Is There an Association of Diffuse Large B-cell Lymphoma with Coronary Artery Disease?

    H. Holik1,2, B. Coha1

  • Abstract Number: PB0161

    Is Viscoelastometric Testing a Good Tool to Assess Hemostasis of COVID-19 Patients?

    M. Bareille1, M. Hardy2, T. Lecompte3, F. Mullier1

  • Abstract Number: PB0484

    Is Zero Bleeds a Realistic Goal for Hemophilia Patients in the Real World Setting?

    A. Adramerina1, A. Teli1, S. Symeonidis1, A. Nianiu1, M. Economou1

  • Abstract Number: PB0539

    Is Zero Bleeds in PWH an Achievable Goal? 3 Years of Emicizumab in Persons with Hemophilia A and Inhibitors in a Portuguese Hemophilia Treatment Centers

    S. Campaniço1, F. Rodrigues1, A. Pereira1, E. Rocha2, G. Cevadinha2, C. Catarino1

  • Abstract Number: PB1176

    ISTH Definition of Pulmonary Embolism-related Death and Classification of the Cause of Death in Venous Thromboembolism Studies: An Autopsy Study

    T. Tritschler1, S.P. Salvatore2, S.R. Kahn3,4, D. Garcia5, A. Delluc6, N. Kraaijpoel7, N. Langlois6, P. Girard8, G. Le Gal6

  • Abstract Number: PB1209

    ISTH Membership and Research Output: A Comparative Study of Sub-Saharan Africa and Europe

    E. Olayemi1, D. Fiawoo2

  • Abstract Number: OC 33.1

    ISTH Registry on Pregnancy and COVID-19 Associated Coagulopathy (COV-PREG-COAG) – First Report

    S. Kazi1, M. Othman2,3, R. Khoury4,5, P. Bernstein6, J. Thachil7, E. Ciantar8, M. Netto9, L. Ferrara9, R. Abdul-Kadir9,10, A. Malinowski11,12

  • Abstract Number: PB0169

    ITP Secondary to COVID-19: A Comprehensive Review of Reported Cases

    B. Berger1, G. Rodgers2

Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley